Pharmaids Pharmaceuticals Limited has announced a board meeting to consider the financial results for the quarter and half-year ending June 30, 2025. The company has also closed its trading window for designated persons and their immediate relatives from July 1, 2025, until 48 hours after the results announcement. This ensures compliance with the company’s insider trading policies and promotes fair market practices for shareholders and stakeholders.